Ticker
$NVO
2 articles on $NVO
kxco sentiment
100% bull0% bear
- $LLYBullish
The Big Business of Longevity
Eight molecules carry an FDA label. Six carry a nonbinding committee vote. The gray market sells the second as though it were the first. A field report on the longevity pipeline, the capital behind it, and the listed names that matter.
Shayne Heffernan14 min - $RAREBullish
The Hottest Biotechs of 2026
Twenty FDA approval actions so far in 2026, eight of them inside a sixteen-day window in August. A first-in-class RAS inhibitor that doubled survival in pancreatic cancer, an oral GLP-1 cleared in fifty days, a first gene therapy for GSDIa, and seven AI platforms with nine assets in humans and nothing yet approved.
Shayne Heffernan45 min